GMPs get the go-ahead...finally
This article was originally published in The Tan Sheet
Office of Management & Budget clears proposed rule on dietary supplement Good Manufacturing Practices Jan. 16. Although reg will be released in the "near future," it may be a "a few weeks" before Federal Register publication, FDA says. Proposed rule has been on tortuous path since February 1997 advanced notice of proposed rulemaking. Reg has twice been returned to FDA by OMB; most recently proposal was sent to OMB Oct. 4...
You may also be interested in...
In what could be a blow to some aspiring developers eyeing the nascent but growing biosimilars market in China, new rules lay out when extrapolation of approved indications of reference biologics will be allowed, meaning this will not be automatic.
Without the MRA that allows unimpeded bilateral device trade between the EU and Switzerland, Swiss industry is having to find ways of limiting the damage that newly erected barriers will cause after the MDR comes into force.
Amneal is set to benefit from 180 days of US exclusivity for its norelgestromin and ethinyl estradiol contraceptive patch product after receiving FDA approval with a competitive generic therapy designation. The generic will be the only competitor to Mylan’s Xulane version.